StockData
Medline Inc. logo

Medline Inc.

MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3060% above fair value
$37.04−0.80 (-2.11%)

Close on Nov 20, 2026Market cap $48.70BP/E –Yield –

Medline Consolidated Adjusted EBITDA Margin by Quarter

Consolidated Adjusted EBITDA Margin (%)

Medline Consolidated Adjusted EBITDA Margin: 12.2% in Q3 2026, up 0.1 pts from a year earlier.

Latest, Q3 2026
12.2%
Period ended Sep 30, 2026
Change on a year earlier
+0.1 pts
12.1% in Q3 2025
History
8 quarters
Since Q4 2024
Sources
4
Documents cited below

Where the Q3 2026 figure comes from

Source: SEC Form 8-K Ex. 99.1 Q3 2026 Earnings Release (2026-11-04) ↗

Reported in SEC Form 8-K Earnings Releases & Form 424B4.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Medline Consolidated Adjusted EBITDA Margin (%), quarterly Q4 2024–Q3 2026 [Data set]. Compiled from Medline SEC filings and investor materials. https://stockdatahq.com/stocks/mdln/kpis/ng-adj-ebitda-margin

See every metric in the Medline KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?